{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:17:15Z","timestamp":1791278235257,"version":"4.1.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1097\/md.0000000000000685","type":"journal-article","created":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T20:18:14Z","timestamp":1430511494000},"page":"e685","source":"Crossref","is-referenced-by-count":62,"title":["Probiotics for Standard Triple Helicobacter pylori Eradication"],"prefix":"10.1097","volume":"94","author":[{"given":"Goran","family":"Hauser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nermin","family":"Salkic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Vukelic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alenka","family":"JajacKnez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davor","family":"Stimac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-6-20210309","doi-asserted-by":"crossref","first-page":"430S","DOI":"10.1093\/ajcn\/73.2.430s","article-title":"Protection from gastrointestinal diseases with the use of probiotics","volume":"73","author":"Marteau","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"R3-6-20210309","first-page":"754","article-title":"Prophylaxis against ampicillin-associated diarrhea with a lactobacillus preparation","volume":"36","author":"Gotz","year":"1979","journal-title":"Am J Hosp Pharm"},{"key":"R4-6-20210309","first-page":"265","article-title":"A controlled clinical study on Streptococcus faecium preparation for the prevention of side reactions during long-term antibiotic treatments","volume":"31","author":"Borgia","year":"1982","journal-title":"Curr Ther Res"},{"key":"R5-6-20210309","first-page":"29","article-title":"Exogenous lactobacilli fed to man. Their fate and ability to prevent diarrheal disease","volume":"7","author":"Clements","year":"1983","journal-title":"Prog Food Nutr Sci"},{"key":"R6-6-20210309","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0016-5085(89)91613-2","article-title":"Prevention of antibiotic associated diarrhea by Saccharomyces boulardii: a prospective study","volume":"96","author":"Surawicz","year":"1989","journal-title":"Gastroenterology"},{"key":"R7-6-20210309","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/07853899009147243","article-title":"Effect of Lactobacillus GG yoghurt in prevention of antibiotic associated diarrhoea","volume":"22","author":"Siitonen","year":"1990","journal-title":"Ann Med"},{"key":"R8-6-20210309","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(87)93078-9","article-title":"Yoghurt with Bifidobacteriumlongum reduces erythromcyin-induced gastrointestinal effects","volume":"2","author":"Colombel","year":"1987","journal-title":"Lancet"},{"key":"R9-6-20210309","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1708-8305.1997.tb00772.x","article-title":"Efficacy of Lactobacillus GG as a diarrheal preventive in travellers","volume":"4","author":"Hilton","year":"1997","journal-title":"J Travel Med"},{"key":"R11-6-20210309","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-3-642-73772-5_70","article-title":"Prophylactic efficacy of lactobacilli on traveller's diarrhea","volume":"7","author":"Black","year":"1989","journal-title":"Travel Med"},{"key":"R12-6-20210309","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3109\/07853899009147242","article-title":"Prevention of traveller's diarrhea by Lactobacillus GG","volume":"22","author":"Oksanen","year":"1990","journal-title":"Ann Med"},{"key":"R13-6-20210309","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00005176-200001000-00018","article-title":"Lactobacillus GG administered in oral rehydration solution to children with acute diarrhea: a multicenter European trial","volume":"30","author":"Guandalini","year":"2000","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R14-6-20210309","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00005176-199711000-00005","article-title":"Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea","volume":"25","author":"Guarino","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R15-6-20210309","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1203\/00006450-199208000-00002","article-title":"Enhancement of the circulating antibody secreting cell response in human diarrhea by a human Lactobacillus strain","volume":"32","author":"Kaila","year":"1992","journal-title":"Pediatr Res"},{"key":"R16-6-20210309","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1007\/BF02087695","article-title":"Oral bacteriotherapy for viral gastroenteritis","volume":"39","author":"Isolauri","year":"1994","journal-title":"Dig Dis Sci"},{"key":"R17-6-20210309","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/00005176-199711000-00005","article-title":"Oral bacterial therapy reduces the duration of symptoms and of viral excretion in children with mild diarrhea","volume":"25","author":"Guarino","year":"1997","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R18-6-20210309","doi-asserted-by":"crossref","first-page":"887","DOI":"10.3109\/00365529609051997","article-title":"Efficacy of SF 68 in the treatment of acute diarrhea. A placebo-controlled trial","volume":"31","author":"Buydens","year":"1996","journal-title":"Scand J Gastroenterol"},{"key":"R19-6-20210309","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1177\/030006058901700405","article-title":"Double-blind report on the efficacy of lactic acid-producing Enterococcus SF68 in the prevention of antibiotic-associated diarrhoea and in the treatment of acute diarrhoea","volume":"17","author":"Wunderlich","year":"1989","journal-title":"J Int Med Res"},{"key":"R20-6-20210309","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1136\/gutjnl-2012-302084","article-title":"European Helicobacter Study Group. Management of Helicobacter pylori infection-the Maastricht IV\/Florence Consensus Report","volume":"61","author":"Malfertheiner","year":"2012","journal-title":"Gut"},{"key":"R21-6-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-5378.2012.00975.x","article-title":"Epidemiology and diagnosis of Helicobacter pylori infection","volume":"17","author":"Tonkic","year":"2012","journal-title":"Helicobacter"},{"key":"R22-6-20210309","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1471-2288-4-26","article-title":"Random allocation software for parallel group randomized trials","volume":"4","author":"Saghaei","year":"2004","journal-title":"BMC Med Res Methodol"},{"key":"R25-6-20210309","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000350719","article-title":"Meta-analysis of bismuth quadruple therapy versus clarithromycin triple therapy for empiric primary treatment of Helicobacter pylori infection","volume":"88","author":"Venerito","year":"2013","journal-title":"Digestion"},{"key":"R26-6-20210309","first-page":"121","article-title":"Lactobacillus rhamnosus GG supplementation to reduce side-effects of anti-Helicobacter pylori treatment","volume":"33","author":"Padilla Ruiz","year":"2013","journal-title":"Rev Gastroenterol Peru"},{"key":"R27-6-20210309","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1365-2036.2007.03480.x","article-title":"Review article: Probiotics in gastrointestinal and liver diseases","volume":"26","author":"Jonkers","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R28-6-20210309","first-page":"103","article-title":"Clinical appliance of probiotics in the treatment of Helicobacter pylori infection: a brief review","volume":"8","author":"Patel","year":"2006","journal-title":"J MicrobiolImmunol Infect"},{"key":"R29-6-20210309","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1128\/AAC.45.11.3156-3161.2001","article-title":"In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics","volume":"45","author":"Pinchuk","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"R30-6-20210309","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MCG.0b013e3182702dbc","article-title":"The use of probiotics in Helicobacter pylori eradication therapy","volume":"47","author":"Medeiros","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"R31-6-20210309","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1523-5378.2007.00565.x","article-title":"Role of probiotics in patients with Helicobacter pylori infection","volume":"12","author":"Franceschi","year":"2007","journal-title":"Helicobacter"},{"key":"R32-6-20210309","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1111\/j.1572-0241.1998.00600.x","article-title":"Lactic acid-mediated suppressionof Helicobacter pylori by the oral administration ofLactobacillussalivarius as a probiotic in a gnotobiotic murine model","volume":"93","author":"Aiba","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"R33-6-20210309","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1471-230X-13-56","article-title":"Association of a probiotic to a Helicobacter pylori eradication regimen does not increase efficacy or decreasesthe adverse effects of the treatment: a prospective, randomized, double-blind, placebo-controlled study","volume":"13","author":"Navarro-Rodriguez","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"R34-6-20210309","doi-asserted-by":"crossref","first-page":"113","DOI":"10.4103\/1319-3767.111953","article-title":"Do probiotics improve eradication response to Helicobacter pylori onstandard triple or sequential therapy?","volume":"19","author":"Dajani","year":"2013","journal-title":"Saudi J Gastroenterol"},{"key":"R35-6-20210309","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1365-2036.2006.03179.x","article-title":"Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy","volume":"25","author":"Tong","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R36-6-20210309","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2036.2010.04457.x","article-title":"Meta-analysis: the effects of Saccharomyces boulardii supplementation on Helicobacter pylori eradication rates and side effects during treatment","volume":"32","author":"Szajewska","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"key":"R37-6-20210309","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/MCG.0b013e318266f6cf","article-title":"Meta-analysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy","volume":"47","author":"Wang","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"R38-6-20210309","first-page":"107","article-title":"Primary resistance of Helicobacter pylori to macrolides and metronidazole in the northern part of Croatia","volume":"17","author":"Plecko","year":"2012","journal-title":"Helicobacter"},{"key":"R39-6-20210309","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1007\/s100960100611","article-title":"European multicentre survey of in vitro antimicrobial resistance in Helicobacter pylori","volume":"20","author":"Glupczynski","year":"2001","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R40-6-20210309","doi-asserted-by":"crossref","first-page":"441","DOI":"10.4321\/S1130-01082013000800001","article-title":"Probiotics for Helicobacter pylori eradication therapy: not ready for prime time","volume":"105","author":"Molina-Infante","year":"2013","journal-title":"Rev Esp Enferm Dig"},{"key":"R41-6-20210309","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/ajg.2014.26","article-title":"A comparative study of sequential therapy and standard triple therapy for Helicobacter pylori infection: a randomized multicenter trial","volume":"109","author":"Zhou","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"R42-6-20210309","first-page":"1","article-title":"Croatian guidelines for diagnostics and treatments of Helicobacter pylori infection","volume":"136","author":"Katicic","year":"2014","journal-title":"LijecVjesn"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000000685","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:42:35Z","timestamp":1620960155000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201505010-00006"}},"subtitle":["A Randomized, Double-blind, Placebo-controlled Trial"],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":38,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000000685","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}